From Seed‑stage risk to Series A valuation
Representative journeys shown below. We focus on the transformation, not just the grant win.
DiagnosticAI — Healthtech
Challenge
Clinical validation pre‑raise
Strategy
NIH Omnibus + NSF Phase I
Result
NIH Phase II $2.1M → $15M Series A
“The NIH grant changed investor conversations. We became fundable.”
DefenseAI Systems — Dual‑Use
Challenge
First customer, long sales cycles
Strategy
DoD SBIR via DSIP with Phase III plan
Result
$2.2M SBIR → $20M Phase III
“They structured Phase I/II with transition in mind.”
GridPower — Cleantech
Challenge
Capital‑intensive R&D
Strategy
NSF + IRAP + SR&ED
Result
$4.9M non‑dilutive → $25M Series A
“We raised from a position of strength.”
Ready to build your funding portfolio?
We’ll map your first 90 days and the parallel opportunities that fit.
Strategic partner for non‑dilutive growth.
Awards are not guaranteed; agency success rates vary by mechanism and institute. Applications are human‑authored; AI tools are internal aids used in compliance with agency policy.
Company
About
Clients
Insights
Services
Funding Portfolio Compliance & Post‑Award Workshops Commercialization
Policies
Methodology & Claims AI & Authorship